Methods and systems for monitoring and modifying a combination treatment

• US 20100041964A1
• Filed: 09/30/2008
• Published: 02/18/2010
• Est. Priority Date: 04/24/2008
• Status: Abandoned Application

• Current Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Hyde, Roderick A., Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Application Number:
  US12/286,730
• Publication Number:
  US 20100041964A1
• Time in Patent Office: Days
• US Class Current: 600/301
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 20/30 relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising

Abstract

Methods, computer program products, and systems are described that include monitoring at least one health attribute of an individual during an artificial sensory experience, associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual, and/or modifying at least one of a bioactive agent or the artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual.

Claims

1-78. -78. (canceled)

79. A system, comprising:

a monitorer module;

an associator module; and

a modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual.

80. The system of claim 79, wherein the monitorer module comprises:

a data receiver module.

81. The system of claim 79, wherein the monitorer module comprises:

a physiological measurement monitorer module.

82. The system of claim 79, wherein the monitorer module comprises:

a neurophysiological activity monitorer module.

83. The system of claim 82, wherein the neurophysiological activity monitorer module comprises:

a physiologic activity measurer module.

84. The system of claim 79, wherein the monitorer module comprises:

a recorder module.

85. The system of claim 79, wherein the monitorer module comprises:

an observer module.

86. The system of claim 79, wherein the associator module comprises:

a physiological response associator module.

87. The system of claim 86, wherein the physiological response associator module comprises:

an artificial sensory experience characteristic associator module.

88. The system of claim 79, wherein the associator module comprises:

a report acceptor module.

89. The system of claim 79, wherein the associator module comprises:

an algorithm utilizer module.

90. The system of claim 79, wherein the associator module comprises:

a comparer module.

91. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

an access modifier module.

92. The system of claim 91, wherein the access modifier module comprises:

a restrictor module.

93. The system of claim 91, wherein the access modifier module comprises:

a granter module.

94. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a visual object modifier module.

95. The system of claim 94, wherein the visual object modifier module comprises:

a color modifier module.

96. The system of claim 94, wherein the visual object modifier module comprises:

a text modifier module.

97. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

an alterer module.

98. The system of claim 97, wherein the alterer module comprises:

a music alterer module.

99. The system of claim 97, wherein the alterer module comprises:

a noise alterer module.

100. The system of claim 97, wherein the alterer module comprises:

a voice alterer module.

101. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

an efficacy modifier module.

102. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a side effect reduction modifier module.

103. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

an adder module.

104. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a deleter module.

105. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a sensate experience modifier module.

106. The system of claim 105, wherein the sensate experience modifier module comprises:

a stimulus modifier module.

107. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a mobile device modifier module.

108. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a dosage modifier module.

109. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a bioactive agent modifier module.

110. The system of claim 79, wherein the modifier module configured to modify at least one of a bioactive agent or an artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of an individual comprises:

a delivery modifier module.